Literature DB >> 11206972

Deletion of the gene encoding H-FABP/MDGI has no overt effects in the mammary gland.

A J Clark1, C Neil, B Gusterson, J McWhir, B Binas.   

Abstract

Heart fatty acid binding protein (H-FABP) is expressed abundantly in the mammary gland. A number of in vitro studies have shown that H-FABP is functionally indistinguishable from a factor isolated from this organ, termed mammary derived growth inhibitor (MDGI), which specifically inhibits the proliferation of mammary tissue. We have previously shown that over-expression of H-FABP/MDGI in the mammary gland of transgenic mice has no discernable effects on cell proliferation or differentiation. In this report we describe knockout mouse in which the H-FABP/MDGI gene has been specifically disrupted. The mice exhibit no overt phenotype in the mammary gland, and we conclude that this gene does not play a specific role in regulating the normal development or function of this tissue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11206972     DOI: 10.1023/a:1026552629493

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  24 in total

1.  A new mouse embryonic stem cell line with good germ line contribution and gene targeting frequency.

Authors:  T M Magin; J McWhir; D W Melton
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

2.  Mammary derived growth inhibitor is not a distinct protein but a mix of heart-type and adipocyte-type fatty acid-binding protein.

Authors:  B Specht; N Bartetzko; C Hohoff; H Kuhl; R Franke; T Börchers; F Spener
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

3.  Stat5a is mandatory for adult mammary gland development and lactogenesis.

Authors:  X Liu; G W Robinson; K U Wagner; L Garrett; A Wynshaw-Boris; L Hennighausen
Journal:  Genes Dev       Date:  1997-01-15       Impact factor: 11.361

4.  Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.

Authors:  G S Hotamisligil; R S Johnson; R J Distel; R Ellis; V E Papaioannou; B M Spiegelman
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

5.  Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.

Authors:  E P Sandgren; J A Schroeder; T H Qui; R D Palmiter; R L Brinster; D C Lee
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

6.  On the mechanism of long chain fatty acid transport in cardiomyocytes as facilitated by cytoplasmic fatty acid-binding protein.

Authors:  M M Vork; J F Glatz; G J Van Der Vusse
Journal:  J Theor Biol       Date:  1993-01-21       Impact factor: 2.691

7.  Hormonal induction of functional differentiation and mammary-derived growth inhibitor expression in cultured mouse mammary gland explants.

Authors:  B Binas; E Spitzer; W Zschiesche; B Erdmann; A Kurtz; T Müller; C Niemann; W Blenau; R Grosse
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

8.  Epithelial proliferation and differentiation in the mammary gland do not correlate with cFABP gene expression during early pregnancy.

Authors:  B Binas; B Gusterson; R Wallace; A J Clark
Journal:  Dev Genet       Date:  1995

Review 9.  Mammary-derived growth inhibitor (MDGI).

Authors:  R Grosse; F D Böhmer; B Binas; A Kurtz; E Spitzer; T Müller; W Zschiesche
Journal:  Cancer Treat Res       Date:  1992

10.  Members of the fatty acid binding protein family are differentiation factors for the mammary gland.

Authors:  Y Yang; E Spitzer; N Kenney; W Zschiesche; M Li; A Kromminga; T Müller; F Spener; A Lezius; J H Veerkamp
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

View more
  3 in total

Review 1.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.

Authors:  Masato Furuhashi; Gökhan S Hotamisligil
Journal:  Nat Rev Drug Discov       Date:  2008-06       Impact factor: 84.694

2.  SHARPIN is an endogenous inhibitor of β1-integrin activation.

Authors:  Juha K Rantala; Jeroen Pouwels; Teijo Pellinen; Stefan Veltel; Petra Laasola; Elina Mattila; Christopher S Potter; Ted Duffy; John P Sundberg; Olli Kallioniemi; Janet A Askari; Martin J Humphries; Maddy Parsons; Marko Salmi; Johanna Ivaska
Journal:  Nat Cell Biol       Date:  2011-09-25       Impact factor: 28.824

3.  Challenges in enriching milk fat with polyunsaturated fatty acids.

Authors:  Jennifer Stamey Lanier; Benjamin A Corl
Journal:  J Anim Sci Biotechnol       Date:  2015-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.